风湿病患者中糖皮质激素性骨质疏松的诊治值得关注
被引量:2
摘要
风湿性疾病可造成多系统多脏器功能损害,近年来,随着对原发病诊治水平的提高,患者的预后得到明显改善。但是,继发骨质疏松症,尤其是应用糖皮质激素引起的骨质疏松(GIOP)越来越成为影响患者生活质量的重要问题。如何正确认识GIOP,如何作到早期诊断及规范治疗,在临床上还未引起足够重视。本文旨在提高对GIOP的警惕,及早进行有效的防治,尽可能避免出现GIOP以及骨折等严重后果。
出处
《中华风湿病学杂志》
CAS
CSCD
2008年第10期657-659,共3页
Chinese Journal of Rheumatology
参考文献14
-
1Mckenzie R, Reynolds JC, O'Fallon A, et al. Decreased bone mineral density during low dose glucocnrticoid administration in a randomized, placebo controlled trial. J Rheumatol. 2000, 27: 2222-2226.
-
2Van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osleoporos Int, 2002, 13: 777-787.
-
3Angeli A Guglielmi G, Dovio A, et al. High prevalence of asymptomatic vertebral fractures in postmenopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study'. Bone, 2006, 39: 253-259.
-
4Kaji H, Yamauchi M, Chihara K, et al. The threshold of bone mineral density for vertebral fracture in female patients with glucocortieoid-induced osteoporosis. Endocr J, 2006, 53: 27-34.
-
5Mendoza-Pinto C, Garcia-Carrasco M, Sandoval-Cruz H, et al. Disease activity and disability but probably not glucoeorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis. Scand J Rheumatol, 2008, 37: 248- 254.
-
6Lee C, Almagor O, Dunlop DD. et al. Disease damage and low bone mineral density:an analysis of women with systemic lupus erythematosus ever and never receiving cort-icosteroids. Rheumatology( Oxford ), 2006, 45: 53-60.
-
7Recommendations for the prevention and glueocortieoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on glucocorticoid-induced osteoporosis. Arthritis Rheum, 2001, 44: 1496-1503.
-
8Hoes JN, Jacobs JWG, Boers M, et al. EULAR evidence-based recommendations on the management of systemic glueocorticoid therapy in rheumatic diseases. Ann Rheum Dis, 2007, 66: 1560-1567.
-
9Buckley LM, Leib ES, Cartularu KS, et al. Calcium and vitamin D supplementation prevents bone loss in the spine secondary to low dose eorticosteroids in patients with rheumatoid arthritis. Ann Intern Med, 1996, 125: 961-968.
-
10De nijs RN, Jacobs JW, Algra A, et al. Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies. Osteoporos lnt, 2004, 15: 589-602.
同被引文献21
-
1陈顺科.糖皮质激素诱发精神异常2例[J].中国药业,2006,15(20):26-26. 被引量:7
-
2廖二元,莫朝晖.内分泌学[M].2版.北京:人民卫生出版社,2010:660.
-
3Feigl GC, Pistracher K, Berghold A, et al. Pituitary insufficiency as a side effect after radiosurgery for pituitary adenomas : the role of the hypothalamus[J]. J Neurosurg, 2010, 113 Suppl: 153-159.
-
4Harsch IA, Schuller A, Hahn EG, et al. Cortisone replacement therapy in endocrine disorders-quality of self-care [ J]. J Eval Clin Pract, 2010, 16(3) :492-498.
-
5Kristjansdottir HL, Bodvarsdottir SP, Sigurjonsdottir HA. Sheehan' s syndrome in modem times : a nationwide retrospective study in Iceland[J]. Eur J Endoerinol, 2011, 164(3) :349-354.
-
6Neary N, Nieman L. Adrenal insufficiency : etiology, diagnosis and treatment [ J ]. Curr Opin Endoerinol Diabetes Obes, 2010, 17 (3) :217-223.
-
7Laway BA, Bhat JR, Mir SA, et al. Shechan's syndrome with pan- cytopenia-eomplete recovery after hormone replacement ( case series with review)[J]. Ann Hematol, 2010, 89(3) :305-308.
-
8徐西嘉,唐劲松,郭文斌.糖皮质激素所致精神障碍2例[J].临床精神医学杂志,2007,17(5):334-334. 被引量:17
-
9张晓.重视风湿病治疗中糖皮质激素诱发的骨质疏松[J].中华内科杂志,2008,47(5):357-358. 被引量:1
-
10卢春燕,张林,徐梁,陈德才,王覃,刘娜,魏松全,贾丹,袁丽.一家大型医院住院患者骨质疏松症诊治现状的初步调查[J].中华骨质疏松和骨矿盐疾病杂志,2010,3(1):43-48. 被引量:15
引证文献2
-
1梁愿,杨娜,王先令,窦京涛,杜锦,吕朝晖,母义明.氢化可的松治疗垂体前叶功能减退症诱发精神障碍3例[J].药物不良反应杂志,2012,14(2):113-115. 被引量:6
-
2郭东更,严晓旭,陈大治,刘媛媛,陈曦,马凤莲,刘小红,陈旭,吕金捍.初发风湿病患者骨质疏松及骨折的临床分析[J].中华风湿病学杂志,2018,22(4):239-245. 被引量:2
二级引证文献8
-
1王璟,侯宁宁,李春英,何明鸿.腺垂体功能减退症30例临床分析[J].中国医师进修杂志,2013,36(27):65-66.
-
2孙建.垂体前叶功能减退症的发病机制分析及治疗进展[J].中国实用医药,2015,10(4):242-243. 被引量:1
-
3王艳,罗娜,刘彦,佘敦敏,冯尚勇,张真稳,于爱民.垂体前叶功能减退患者治疗中出现精神症状因素分析[J].医学理论与实践,2016,29(17):3037-3039. 被引量:4
-
4尹寿祥,姜超.临床药师对腺垂体功能减退症患者精神异常的药学监护[J].中国医院用药评价与分析,2017,17(5):710-711. 被引量:3
-
5张新菊,孙燕,李雁,崔潇镱,李金峰,刘武,张润云.FRAX联合DXA对骨质疏松症患者骨折的预测效果研究[J].重庆医科大学学报,2019,44(9):1171-1175. 被引量:6
-
6叶彬,黄彦弘,章璐,田小兰,张清,卢敏辉,徐鹏慧,郭娟,孔祥艳,周惠琼.多中心风湿病患者应用骨折风险评估模型评估骨折风险的临床分析[J].中华医学杂志,2019,99(42):3345-3349. 被引量:2
-
7李萍,陈若然,梁琳琅.小剂量泼尼松治疗腺垂体功能低下患者引发精神症状1例诊治体会[J].内科急危重症杂志,2019,25(5):435-437. 被引量:5
-
8李立,卢姗,潘丹,王倩.氢化可的松和莫西沙星致肾上腺皮质功能减低患者谵妄1例[J].药物流行病学杂志,2019,28(2):137-138. 被引量:2
-
1曾燕,梁敏.糖皮质激素性骨质疏松机制的研究进展[J].内科,2009,4(6):911-914. 被引量:2
-
2连莉,徐建华.糖皮质激素性骨质疏松防治进展[J].临床内科杂志,2011,28(10):653-655. 被引量:2
-
3饶进.特发性血小板减少性紫癜患者糖皮质激素性骨质疏松的防治[J].中国社区医师(医学专业),2013,15(4):122-123. 被引量:1
-
4索颖,索玲.重症急性胰腺炎的护理体会[J].中国实用医药,2006,1(4):80-81. 被引量:1
-
5朱正华,李承球,赵宝成,徐爱军,司马义柱.人工股骨头置换治疗36例高龄股骨粗隆间骨折[J].中国临床研究,2011,24(12):1119-1120.
-
6泽多.急性重症胰腺炎的诊断及治疗进展[J].西藏医药,2007,28(4):27-29.
-
7范金花,袁晓燕,初阿妮.重症急性胰腺炎的观察与护理[J].菏泽医学专科学校学报,2013,25(1):72-73. 被引量:4
-
8陈铮.老年十二指肠溃疡急性穿孔诊治体会[J].国际医药卫生导报,2002,8(05B):60-61.
-
9聂元初.136例重症急性胰腺炎的处理体会[J].医学临床研究,2005,22(2):262-264. 被引量:3
-
10朱玉萍.重症急性胰腺炎患者的护理干预[J].中国实用医药,2009,4(5):190-191. 被引量:1